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Spondyloepiphyseal dysplasia (SED) encompasses a heterogeneous group of disorders characterized by shortening
of the trunk and limbs. The autosomal dominant SED type Kimberley (SEDK) is associated with premature de-
generative arthropathy and has been previously mapped in a multigenerational family to a novel locus on 15q26.1.
This locus contains the gene AGC1, which encodes aggrecan, the core protein of the most abundant proteoglycan
of cartilage. We screened AGC1 for mutations and identified a single–base-pair insertion, within the variable repeat
region of exon 12 in affected individuals from the family with SEDK, that introduces a frameshift of 212 amino
acids, including 22 cysteine residues, followed by a premature stop codon. This is the first identification of an
AGC1 mutation causing a human disorder. This finding extends the spectrum of mutated genes that may cause
SED and thus will aid in the molecular delineation of this complex group of conditions.
The spondyloepiphyseal dysplasia (SED) phenotype en-
compasses a heterogeneous group of chondrodysplasias
with radiographic abnormalities of the vertebral bodies
and proximal epiphyses (Horton 2002). The autosomal
dominant SED congenita (MIM 183900) and the X-
linked recessive SED tarda (MIM 313400) are specific
subtypes that are caused by mutations in the type II
collagen gene (COL2A1 [MIM 120140]) and the sedlin
gene (SEDL [MIM 300202]), respectively. Autosomal
dominant SED type Kimberley (SEDK [MIM 608361])
is a mild autosomal dominant form of SED that was
identified in a multigenerational South African family of
U.K. white descent. The phenotype of SEDK is short
stature (!5th percentile for age), stocky build, and early-
onset osteoarthritis of the weight-bearing joints. Radio-
graphic features are flattened vertebral bodies, with scle-
rosis and end-plate irregularity, and flattened femoral
epiphyses (Anderson et al. 1990). Previous linkage stud-
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ies excluded linkage to COL2A1 (Anderson et al. 1990),
and a genome screen identified a novel locus for this
disorder on chromosome 15q26.1 (Eyre et al. 2002). The
candidate gene AGC1 (MIM 155760) was initially ex-
cluded from the linked region, but revised genotyping
performed using a SNP within exon 18 (NCBI dbSNP
accession number rs2280467), coupled with the variable
repeat region (VNTR) within exon 12 (Eyre et al. 2002)
and a SNP within intron 1 (NCBI dbSNP accession num-
ber rs4932200), confirmed that the gene is within the
critical region (fig. 1) (Eyre et al. 2005).
The AGC1 gene was considered to be a strong can-
didate gene for SEDK because it encodes the core protein
of aggrecan, a major component of the cartilage extra-
cellular matrix (ECM), and because AGC1 mutations
have previously been found to cause forms of chon-
drodysplasia in the mouse and chick. The lethal mouse
disorder cartilage matrix deficiency (cmd), characterized
by cleft palate and short limbs, tail, and snout, is caused
by homozygosity of a 7-bp deletion that results in a
frameshift and a premature termination of the aggrecan
core protein (Watanabe et al. 1994). Heterozygotes for
the cmd mutation appear normal at birth but, within
28 d after birth, are dwarfed and have age-related spinal
misalignment that leads to premature death (Watanabe
et al. 1997). The phenotype of the cmd-Bc mouse is
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Figure 1 Pedigree of family with SEDK. Blackened circles and squares represent affected females and males, respectively. Haplotypes for
subjects who were genotyped are given under the symbols. The disease-linked haplotype is boxed. Genotypes of microsatellite markers are as
published previously (Eyre et al. 2002). The marker order (top to bottom) is D15S205, AGC1 intron 1 SNP, AGC1 VNTR, AGC1 exon 18
SNP, D15S116, and D15S1004.
similar to that of cmd and results from the near-complete
deletion of the murine aggrecan gene (Krueger et al.
1999). Homozygosity for a premature stop codon in the
chick aggrecan gene causes nanomelia, a lethal disorder
of cartilage development in which embryos have short-
ened and malformed limbs (Li et al. 1993). Heterozy-
gosity for the nanomelia mutation results in a shortening
of the long bones of the legs (Landauer 1965).
The 19-exon structure of the human AGC1 gene has
been described in detail elsewhere (Doege et al. 1991;
Valhmu et al. 1995). Briefly, exon 1 is noncoding and
is separated from the remaining coding exons by a 13-
kb intron. Exons 2–19 encode the aggrecan core protein,
which comprises a central glycosaminoglycan attach-
ment domain flanked by three globular domains. The
amino terminal G1 (hyaluronan binding) and G2 glob-
ular domains plus an interglobular domain are encoded
by exons 3–10. The keratan sulfate attachment domain
is encoded by exon 11 and part of exon 12. The re-
mainder of exon 12 encodes the chondroitin sulfate at-
tachment domains (CS1 and CS2), including a VNTR
of 13–33 repeats of 57 nt within the CS1 domain (Doege
et al. 1997). The G3 domain, containing the C-lectin
domain, has a role in intracellular trafficking and in
secretion from the cell and is encoded by alternatively
spliced exons from exons 13 to 18 (Domowicz et al.
2000) (fig. 2).
Affected individuals of the family with SEDK were
screened by PCR followed by direct sequencing (PCR
primer sequences and conditions are available upon re-
quest) for mutations within the 19 exons (but excluding
the VNTR region) and for splice-acceptor and/or splice-
donor sequences of AGC1. The analysis of these exons
did not identify any potential mutations. The linked
VNTR allele (allele 3) in the family with SEDK (fig. 1)
could be amplified as a 1.5-kb PCR fragment, but it was
intractable to direct sequencing, because of its repeating
sequence. Therefore, the VNTR region was first ampli-
fied, as described elsewhere (Doege et al. 1997), from
genomic DNA of family members III-5, IV-4, and IV-5,
who had genotypes of 2/3, 3/3, and 3/4, respectively (fig.
1). The PCR products were cloned into the pGEM-T
Easy vector (Promega), and the clones were analyzed to
determine which allele they contained. Clones contain-
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Figure 3 Sequence of AGC1 VNTR clones from individual IV-4, shown in reverse orientation. The division between repeats is indicated
by double vertical lines, and repeat numbers are shown in bold type. Sequence variations are indicated by a shaded box around the nucleotide.
A, The sequence trace shows the SNP used to distinguish the linked from the unlinked VNTR allele 3 clones. B, The sequence trace shows a
1-bp insertion of a C in the 15th repeat (arrow) in the linked but not in the unlinked allele 3.
ing the linked allele 3 from III-5 (9 clones) and IV-5 (3
clones) were distinguished from those with the unlinked
alleles 2 and 4 on the basis of size, by separation on a
0.6% (weight/volume) agarose gel. For individual IV-4
(homozygous for allele 3), 10 clones were partially se-
quenced from both the 5′ and the 3′ ends, and the linked
allele was distinguished from the unlinked allele on the
basis of an A sequence variant (7 clones) versus a G
sequence variant (3 clones) in the third repeat from the
3′ end (fig. 3).
Deletion sets were generated from the 3′ ends of the
two cloned alleles from each individual by use of the
Erase-a-base system protocol (Promega). Briefly, cloned
VNTR alleles in the sense orientation were digested with
the restriction enzymes SpeI and NsiI, which have sites
within the pGEM-T Easy multiple-cloning site but not
within the VNTR, followed by timed exonuclease III
digestion, S1 nuclease digestion, and religation. Deleted
subclones representing each allele were sequenced from
the 3′ end of the inserted sequence by use of the SP6
vector primer. Sequence variation between repeats al-
lowed the deleted clones for each allele to be aligned.
From this, we determined that allele 3 contained 27 re-
peats of the 57-nt VNTR sequence. In the 15th repeat
of the linked allele 3 from III-5, IV-4, and IV-5, a unique
insertion of a single C was identified (fig. 3). The pre-
dicted effect of this mutation would be a frameshift,
altering the sequence of the 212 aa that follow (including
the introduction of 21 cysteine residues), followed by a
premature stop codon within the CS1 domain (fig. 4).
To confirm that the insertion was not the result of a
sequencing artifact, Kozak sequences were inserted into
the cloned alleles of IV-4 and IV-5, and the clones were
used as templates for in vitro transcription by the Ribo-
Max large scale RNA T7 production kit (Promega), fol-
lowed by in vitro translation by the FlexiRabbit Retic-
ulocyte Lysate System in the presence of radiolabeled
35S-cysteine or 14C–amino acid mix. The cloned linked
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Figure 4 Predicted translation of the normal and mutant VNTR allele 3 clones. Cysteine residues are boxed. The sequence starts at amino
acid 944 of the aggrecan core protein sequence.
and unlinked VNTR alleles in the sense orientation were
linearized with ApaI and SacII. The two oligonucleotide
primers, 5′-CAGCCACCATGGCGC-3′ and 5′-GCCAT-
GGTGGCTGGGCC-3′, were synthesized and annealed
together and were then ligated into the linearized plas-
mids, thereby introducing a Kozak sequence plus an in-
frame ATG 5′ of the AGC1 VNTR sequence. In vitro
transcription and translation were performed, and the
translation products were separated by SDS-PAGE (4%–
12%) and were visualized by autoradiography.
The 14C–amino acid mix labeled both the normal and
the mutant translation products (fig. 5A), whereas, as
expected from the predicted frameshift, 35S-cysteine la-
beled only the mutant translation products (fig. 5B). The
faster migration of the mutant, compared with that of
the normal translation product, cannot be attributed to
their 1.4-kD difference in estimated molecular weight
but is presumably the result of the increased hydropho-
bicity and altered proline content of the mutant protein,
which are caused by the frameshift (as discussed by
Iakoucheva et al. [2001]).
Amplification refractory mutation system (ARMS)
was used to confirm the inheritance of the mutation
by affected individuals. Allele-specific amplification was
performed from genomic DNA with the use of the
wild-type–specific sense primer 5′-GAAGTTCTAGA-
GACTGCTGCCCC-3′ and the destabilized mutant-
specific sense primer 5′-GAAGTTCTAGAGACTGCT-
GCCACC-3′ in separate PCR reactions, with each sense
primer paired with the VNTR generic antisense primer
5′-AGGTCCCCTACCGCAGAGGTAGAA-3′. A 50-ml
PCR reaction included 20 pmol of either sense primer,
20 pmol of the generic antisense primer, 0.2 mM dNTPs,
2.5 U of Taq DNA polymerase (Bioline), 10 # PCR
buffer, and 2 mM MgCl2. The annealing temperature
was 65C, and amplification was performed for 29 cycles
on a Cetus Thermal Cycler (PerkinElmer). All affected
individuals of generation IV were shown to have the
mutated sequence on the linked allele 3 but not on the
unlinked alleles (fig. 6). Similar screening of the alleles
from 108 unrelated U.K. white control individuals did
not identify this mutation.
The cosegregation of the molecular defect with SEDK-
affected members of the family and its absence in 216
alleles from a control population support the idea that
heterozygosity for the 1-bp insertion in AGC1 is the
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Figure 6 ARMS products after electrophoresis on a 1% (weight/
volume) agarose gel. Lane 1, 1-kb ladder (Bioline). Lanes 2, 4, 6, 8,
10, and 12, the products obtained when amplified with the normal
oligonucleotide. Lanes 3, 5, 7, 9, 11, and 13, the products obtained
when amplified with the destabilized mutant oligonucleotide. DNA
was amplified from individual IV-1 (lanes 2 and 3), individual IV-2
(lanes 4 and 5), individual IV-3 (lanes 6 and 7), individual IV-4 (lanes
8 and 9), individual IV-5 (lanes 10 and 11), and individual IV-6 (lanes
12 and 13).
Figure 5 Products of the in vitro transcription and translation
of normal and mutant VNTR allele 3 clones after separation by SDS-
PAGE under reducing conditions. A, Translation in the presence of
radiolabled 14C–amino acid mix. Lane 1, luciferase control (Promega);
lane 2, individual IV-4 normal allele 3; lane 3, individual IV-4 mutant
allele 3; lane 4, individual IV-5 normal allele 4; lane 5, individual IV-
5 mutant allele 3; lane 6, no-RNA template control. B, Translation in
the presence of 35S-cysteine. Lane 1, luciferase control (Promega); lane
2, individual IV-4 normal allele 3; lane 3, individual IV-4 mutant allele
3; lane 4, individual IV-5 normal allele 4; lane 5, individual IV-5 normal
allele 3; lane 6, no-RNA template control.
cause of SED in this kindred. The position of the mu-
tation predicts the synthesis of a truncated protein from
the mutant allele that is ∼60% of the normal size. The
truncated protein would lack half of the CS1 domain,
the complete CS2 domain, and the G3 domain but would
include novel sequence of 212 aa (fig. 2). In comparison,
the nanomelia mutation is the transversion of GrT in
a codon for Glu (GAA) that introduces a premature stop
codon (but no frameshift) in the chick-specific, 20-aa
repeat region of the CS2 domain; hence, the truncated
protein lacks part of the CS2 domain and the G3 do-
main. The nanomelia mutation causes a reduction in the
steady-state levels of aggrecan mRNA to ∼6% of normal
levels (Stirpe et al. 1987), but the residual mRNA is
translated. The truncated protein is retained and accu-
mulates in the endoplasmic reticulum (ER) (Li et al.
1993; Vertel et al. 1993) but is not secreted into the
ECM. The cmd mutation is similar to the nanomelia
mutation, in that it causes a reduction in the steady-state
levels of aggrecan mRNA to 41% of normal levels in
the homozygote and to 81% of normal levels in the
heterozygote (Watanabe et al. 1997). In contrast to the
nanomelia mutation, however, the potentially truncated
32-kD cmd polypeptide has not been detected in the ER
but, as expected, is absent from the ECM. The cmd
mutation thus shows that the reduction or absence of
aggrecan in the ECM is sufficient to cause chondro-
dysplasia. What is not clear, though, is whether the re-
tention of the truncated protein by nanomelic chondro-
cytes impairs their function and thereby exacerbates the
phenotype of the reduction (in the heterozygote) or ab-
sence (in the homozygote) of aggrecan in the ECM. The
cmd and nanomelia mutations therefore predict that the
SEDK AGC1 mutation may result in reduced mRNA
from the mutant allele and that the truncated translation
product may be retained and may accumulate within the
ER. Further studies are required to establish whether the
truncated protein, with its additional novel residues, is
synthesized and, if so, to determine both its effect on
other proteins within the ER and on chondrocyte func-
tion and its contribution to the SEDK phenotype.
This is the first report of an AGC1 mutation causing
a heritable form of human chondrodysplasia. The AGC1
gene is thus a strong candidate for as-yet uncharacterized
forms of SED. Genotype-phenotype correlations will in-
form studies aimed at understanding the molecular con-
sequences of specific AGC1 mutations on chondrocyte
function and skeletogenesis.
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